Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing

PCI Positions MyGenome as Southeast Asia’s Reference Laboratory for Drug Interaction Safety Science

KUALA LUMPUR, Malaysia, Nov. 12, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced the launch of its Pharmaco-Interaction (PCI) laboratory unit within its MyGenome subsidiary, with CYP450 inhibitory IC50 testing debuting as its first commercial service offering.

The MyGenome laboratory facility in Kuala Lumpur, Malaysia, home to the newly launched Pharmaco-Interaction (PCI) unit.

PCI will start with cytochrome P450 (CYP450) inhibitory IC50 testing across seven major enzyme isoforms (CYP3A4, CYP2D6, CYP2C9, CYP1A2, CYP2C19, CYP2B6, and CYP2E1), collectively responsible for metabolizing approximately 90% of marketed clinical drugs, supporting safe use, regulatory compliance, and consumer confidence. FDA and EMA guidelines recommend CYP inhibition evaluation for clinical and botanical drugs. PCI will make this service available to herbal and supplement manufacturers, pharmaceutical companies, and research institutions.

“Every service we launch is a building block toward becoming Southeast Asia’s integrated life sciences reference platform,” said Dr. Tham Seng Kong, Executive Director and Group Chief Executive Officer of Alps Group Inc. “The region has a significant and growing herbal and botanical products industry, yet access to accredited CYP inhibition testing has remained limited. PCI addresses that gap converting our scientific infrastructure into a revenue-generating capability that meets the regulatory standards already demanded by the market.”

“The assumption that all natural products are inherently safe, especially in consumption with prescription drugs, is one of the most persistent misconceptions in healthcare,” said Professor Nik Soriani, PCI Scientific Lead at MyGenome. “CYP450 inhibition testing is already recommended by the FDA and EMA for clinical and botanical products. PCI intends to make that standard accessible to manufacturers and researchers across Southeast Asia. We are building the reference laboratory Southeast Asia has been missing.”

LC-MS/MS Triple Quadrupole used for CYP450 inhibitory IC50 testing across seven major enzyme isoforms at Alps Group Inc’s MyGenome subsidiary.

PCI joins a growing suite of high-value B2B services within Alps’ laboratory portfolio, as the Company expands its capabilities across precision oncology, genomics, and translational research, with the goal of establishing Malaysia as a regional hub for ethical life science services.

About Alps Group Inc
Alps Group Inc is a revenue-generating integrated biotechnology platform headquartered in Malaysia, operating across cell manufacturing, molecular diagnostics, and clinical delivery. Alps leverages revenue from its commercial businesses to support its clinical pipeline development, with a mission to make advanced precision medicine accessible and affordable across Southeast Asia.

Forward-Looking Statements
Certain statements in this press release may be considered to contain certain “forward-looking statements” within the meaning of “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “target,” “believe,” “expect,” “will,” “shall,” “may,” “anticipate,” “estimate,” “would,” “positioned,” “future,” “forecast,” “intend,” “plan,” “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s management’s current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

A further list and description of risks and uncertainties can be found in documents filed with or furnished to the Securities and Exchange Commission (“SEC”) by the Company and other documents that we may file with or furnish to the SEC, which you are encouraged to read. Any forward-looking statement made by us in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, or otherwise, except as required by law.

Investor Relations Contact

Alps Group Inc
Investor Relations
Phone: +60 3-2163 1113
Email: [email protected] 

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/66efa1e1-8981-46a8-a974-28de896bd6f0

https://www.globenewswire.com/NewsRoom/AttachmentNg/6cbc1f80-900a-4ccd-acbd-1b63ea07f790



Seanergy Maritime Reports Third Quarter and Nine-Month 2026 Financial Results

Delivers Record Nine-Month Net Income of $61.9 Million; Raises Quarterly Cash Dividend to $0.40 Per Share, Bringing Cumulative Dividends to $3.59 Per Share

Expands Fleet Investment Program to $855 Million – Twelve Capesize and Newcastlemax Vessels Adding 2.3 Million DWT

Highlights            

(in million USD, except EPS and TCE)
  Q3 2026 Q3 2025 9M 2026 9M 2025 9M YoY
Growth
(%)
Net Revenues   $57.5 $47.0 $155.2 $108.7 43%
Net Income   $26.0 $12.8 $61.9 $8.8 604%
Adjusted Net Income1   $27.0 $14.0 $69.0 $12.3 459%
EBITDA1   $39.4 $27.5 $102.2 $51.5 98%
Adjusted EBITDA1   $40.8 $28.9 $110.5 $55.1 100%
             
Fleet TCE2   $34,266 $23,476 $30,216 $19,031 59%
             
Earnings per share Basic & Diluted   $1.20 $0.61 $2.87 $0.42 583%
Adjusted Earnings per share Basic1   $1.25 $0.67 $3.21 $0.60 435%
Adjusted Earnings per share Diluted1   $1.25 $0.67 $3.21 $0.59 444%



Other Highlights and Developments:


Record Nine-Month Performance and Consistent Shareholder Returns

  • Delivered another highly profitable quarter, bringing nine-month Net Income to a record $61.9 million, Adjusted EBITDA to $110.5 million and Adjusted EPS to $3.21.
  • Declared a quarterly cash dividend of $0.40 per share, marking Seanergy’s 20th consecutive quarterly distribution.


Disciplined Fleet Renewal and Selective Growth

  • Added four high-quality vessels for aggregate consideration of approximately $264 million, comprising:
    • a modern 2019-built Japanese Capesize, expected to join the fleet in January 2027;
    • a 2014-built Japanese Newcastlemax for delivery in the second half of 2029;
    • a Japanese-built Capesize newbuilding for delivery in the second half of 2029; and
    • a 210,000 dwt Newcastlemax newbuilding at Hengli, scheduled for Q1 2029.
  • Agreed the sale of a 2009-built Capesize vessel for $33.0 million, expected to generate approximately $19.6 million in net liquidity and a book gain of approximately $12.4 million, closely aligning the disposal of the fleet’s oldest vessel with the deliveries of the modern 2019-built Japanese Capesize and our first newbuilding.
  • The current fleet investment program now comprises twelve vessels – nine newbuildings and three Japanese-built eco secondhand Capesize and Newcastlemax vessels – totaling approximately $855 million and 2.3 million dwt, with deliveries staggered from January 2027 through 2029.
  • Strong employment coverage for upcoming deliveries, with four of the six vessels scheduled for delivery in 2027–2028 having secured, or being close to securing, multi-year charters with first-class charterers, combining profitable floor rates with index-linked upside.

________________________
1 Adjusted earnings per share, Adjusted Net Income, EBITDA and Adjusted EBITDA are non-GAAP measures. Please see the reconciliation below of Adjusted Earnings per share, Adjusted Net Income, EBITDA and Adjusted EBITDA to Net Income, the most directly comparable U.S. GAAP measure.
2 Time Charter Equivalent (“TCE”) rate is a non-GAAP measure. Please see the reconciliation below of TCE rate to Net Revenues from vessels, the most directly comparable U.S. GAAP measure.

ATHENS, Greece, Nov. 12, 2026 (GLOBE NEWSWIRE) — Seanergy Maritime Holdings Corp. (“Seanergy” or the “Company”) (NASDAQ: SHIP), a leading pure-play Capesize owner and operator, today reported its financial results for the third quarter and nine months ended September 30, 2026. The Company also declared a quarterly cash dividend of $0.40 per common share, increased from the $0.35 per share declared last quarter, marking Seanergy’s 20th consecutive quarterly dividend under its capital return policy and reflecting its strong earnings generation and disciplined approach to capital allocation.

For the quarter ended September 30, 2026, the Company generated Net Revenues of $57.5 million, compared to $47.0 million in the third quarter of 2025. Net Income increased to $26.0 million from $12.8 million, while Adjusted Net Income increased to $27.0 million from $14.0 million. EBITDA and Adjusted EBITDA reached $39.4 million and $40.8 million, respectively, compared to $27.5 million and $28.9 million, respectively, for the same period of 2025. The fleet achieved a daily TCE of $34,266, representing a 46% year-over-year increase.

For the nine months ended September 30, 2026, Seanergy generated Net Revenues of $155.2 million, compared to $108.7 million in the first nine months of 2025. Net Income increased to $61.9 million from $8.8 million for the same period in 2025, while Adjusted Net Income increased to $69.0 million from $12.3 million. Adjusted EBITDA doubled to $110.5 million, and Adjusted EPS reached $3.21, compared to $0.60 for the same period in 2025. Fleet TCE increased by 59% to $30,216 per day.

Cash and cash equivalents and restricted cash, as of September 30, 2026, stood at $167.9 million. Long-term debt (senior loans and other financial liabilities, including our senior unsecured bond) net of deferred charges amounted to $409.7 million, compared with a fleet book value of $575.7 million, including advances paid for vessels under construction and a vessel under sales-type lease. Stockholders’ equity increased over the nine-month period to $333.1 million.

Stamatis Tsantanis, the Company’s Chairman & Chief Executive Officer, stated:

“Seanergy delivered another highly profitable quarter, earning a TCE of $34,266 per day, up 46% year-over-year, and bringing nine-month Net Income to a record $61.9 million and Adjusted EPS to $3.21. This performance underscores the significant operating leverage of our pure-play Capesize platform in a strong market.

“Our board of directors raised the quarterly cash dividend to $0.40 per share – double the first-quarter level – marking our 20th consecutive distribution. Including buybacks, we have now returned approximately $117.0 million to our shareholders since the inception of our program. We are raising distributions while comfortably funding a large fleet investment program. We do not trade-off shareholder returns for growth.

“In January 2027, we expect to take delivery of the first newbuilding in Seanergy’s history, approximately four months ahead of schedule, together with the modern 2019-built Japanese Capesize M/V Midnightship. The deliveries will coincide with the planned sale of the 2009-built M/V Friendship.

“With four vessels added this quarter, representing an approximately $264 million investment, our program now comprises twelve vessels, approximately $855 million investment and 2.3 million dwt of additional capacity – expanding our fleet’s carrying capacity by more than 50%. We contracted early, and values have moved in our favor since. Based on market report valuations, the newbuilding vessels are worth approximately $85.0 million more than their contract prices, representing significant value that is not reflected on our balance sheet.

“Of the six vessels scheduled to deliver in 2027 and 2028, four have secured, or are close to securing, multi-year employment with first-class charterers. These charters combine profitable floor rates with index-linked upside, providing downside protection from delivery while retaining meaningful participation in a strong Capesize market.

“The program’s funding is progressing well, supported by strong cash reserves of $167.9 million, a staggered payment schedule with the largest instalments falling due upon the respective deliveries, and diversified sources of capital. On that basis, we remain well positioned to execute our strategy while preserving our balance sheet strength and maintaining cash distributions to our shareholders.

“Twelve vessels give us the scale, fleet profile and delivery visibility to meet our medium-term objectives. The focus shifts to execution – financing, employing and integrating these vessels as they are delivered, while preserving the flexibility to act selectively on attractive opportunities.

“The Capesize market performed strongly in the third quarter, supported by record bauxite volumes, continued growth in iron ore ton-mile demand and resilient coal trades. Market fundamentals remain constructive, underpinned by relatively limited fleet growth, an ageing Capesize fleet and increasing voyage distances driven by rising West African and Brazilian exports of iron ore and bauxite. With approximately 86% of fourth-quarter days already fixed, we expect Q4 TCE to reach approximately $33,284 per day, resulting in full-year 2026 TCE of approximately $31,000 per day, up roughly 48% compared to 2025.

“Our strategy is working: strong earnings are funding both a rising dividend and a transformational fleet renewal, while older vessels are monetized at firm market values. Seanergy enters 2027 from a position of financial and commercial strength, supported by increasing earnings, contracted cash flows, a modernizing fleet and a clear focus on enhancing long-term value per share.”

Company Fleet
:

Vessel Name Capacity (DWT) Year

Built
Yard Scrubber Fitted Employment Type FFA conversion option
(
1)
Minimum time charter (“T/C”) expiration Maximum T/C expiration
(
2)
Charterer
Titanship 207,855 2011 NACKS – T/C Index Linked(3) No 09/2026 03/2027 Cargill
Meiship 207,851 2013 Imabari – T/C Index Linked Yes 01/2028 06/2028 Glencore
Patriotship 181,709 2010 Imabari Yes T/C Index Linked Yes 01/2028 03/2028 Glencore
Paroship 181,415 2012 Koyo -Imabari Yes T/C Index Linked Yes 07/2027 12/2027 Oldendorff
Worldship 181,415 2012 Koyo – Imabari Yes T/C Index Linked Yes 11/2026 03/2027 NYK
Kaizenship 181,396 2012 Koyo Dock – T/C Index Linked Yes 01/2028 06/2028 Oldendorff
Iconship 181,392 2013 Imabari – T/C Index Linked Yes 03/2027 07/2027 K Line
Hellasship 181,325 2012 Imabari – T/C Index Linked Yes 04/2027 08/2027 NYK
Honorship 180,242 2010 Imabari – T/C Index Linked Yes 03/2028 06/2028 NYK
Fellowship 179,701 2010 Daewoo – T/C Index Linked Yes 01/2028 03/2028 Anglo American
Championship 179,238 2011 Sungdong Yes T/C Index Linked Yes 04/2027 08/2027 Cargill
Partnership 179,213 2012 Hyundai Yes T/C Index Linked Yes 01/2027 05/2027 Glencore
Knightship 178,978 2010 Hyundai Yes T/C Index Linked Yes 12/2026 04/2027 Glencore
Lordship 178,838 2010 Hyundai Yes T/C Index Linked Yes 01/2027 03/2027 Glencore
Blueship 178,459 2011 Mitsui – T/C Index Linked Yes 12/2027 04/2028 NYK
Friendship(4) 176,952 2009 Namura – T/C Index Linked Yes 04/2027 09/2027 Glencore
Flagship 176,387 2013 Mitsui – T/C Index Linked Yes 10/2027 02/2028 Cargill
Premiership 170,024 2010 Sungdong Yes T/C Index Linked Yes 01/2028 03/2028 Glencore
Total /

Average age
3,282,390 15.3 years – – – – – – –
Vessels under construction
TBN Primeship 181,000 2027 Hengli Yes T/C Index Linked(5) – 5 years(6) European Operator
TBN Chrysship 181,500 2027 Hengli Yes T/C Index Linked(5) – 5 years(6) European Operator
NB Vessel 181,500 2027 Hengli Yes T/C Index Linked(5) – 4 years(7) Major Miner
TBN Nikiship 181,500 2027 Japanese Yard Yes – – – – –
TBN Megaship 211,000 2028 Hantong Yes – – – – –
TBN Kingship 181,500 2029 Japanese Yard Yes – – – – –
NB Vessel 181,000 2029 Japanese Yard Yes – – – – –
NB Vessel 181,000 2029 Japanese Yard Yes – – – – –
NB Vessel 210,000 2029 Hengli Yes – – – – –
Vessels to be delivered
TBN 182,000 2022 Japanese Yard – – – – – –
TBN 210,000 2014 Japanese Yard – – – – – –
TBN Midnightship 180,000 2019 Japanese Yard – – – – – –
Bareboat charter out
Dukeship 181,453 2010 Sasebo – Bareboat – 08/2027 09/2027 United

(1) The Company has the option to convert the index-linked rate to fixed for periods ranging between 1 and 12 months, based on the prevailing Capesize FFA rate for the selected period.
   
(2) The latest redelivery date does not include any additional optional periods.
   
(3) The time charter agreement provides a fixed floor rate. Above the floor, the hire is calculated based on a significant premium over the BCI-180, with incremental earnings shared equally between Seanergy and the respective charterer.
   
(4) The vessel is expected to be delivered to her new owners in early Q1 2027.
   
(5) The time charter agreement provides a floor rate. Above the floor, the hire is calculated at a significant premium over the BCI-180 up to an upper threshold, and above the upper threshold, the hire is calculated based on the same premium over the BCI-180, with incremental earnings shared equally between Seanergy and the respective charterer.
   
(6) The time charter agreement provides three optional extension periods of minimum 10 to maximum 14 months each.
   
(7) The time charter agreement provides two optional extension periods of about 11 to about 13 months each.
   

Fleet Data:

(U.S. Dollars in thousands)

  Q3 2026


  Q3 2025


  9M 2026


  9M 2025


 
Ownership days (1) 1,656   1,911   5,115   5,600  
Operating days (2) 1,634   1,856   4,990   5,363  
Fleet utilization (3) 98.7%   97.1%   97.6%   95.8%  
TCE rate (4) $34,266   $23,476   $30,216   $19,031  
Daily Vessel Operating Expenses (5) $6,699   $7,376   $6,999   $7,086  

(1) Ownership days are the total number of calendar days in a period during which the vessels in a fleet have been owned or chartered in. Ownership days are an indicator of the size of the Company’s fleet over a period and affect both the amount of revenues and the amount of expenses that the Company recorded during a period.
   
(2) Operating days are the number of available days in a period less the aggregate number of days that the vessels are off-hire due to unforeseen circumstances. Available days are the number of ownership days less the aggregate number of days that our vessels are off-hire due to major repairs, dry-dockings, lay-up or special or intermediate surveys. Operating days include the days that our vessels are in ballast voyages without having finalized agreements for their next employment. The Company’s calculation of operating days may not be comparable to that reported by other companies.
   
(3) Fleet utilization is the percentage of time that the vessels are generating revenue and is determined by dividing operating days by ownership days for the relevant period. Fleet Utilization is used to measure a company’s ability to efficiently find suitable employment for its vessels and minimize the number of days that its vessels are off-hire for unforeseen events. We believe it provides additional meaningful information and assists management in making decisions regarding areas where we may be able to improve efficiency and increase revenue and because we believe that it provides useful information to investors regarding the efficiency of our operations. The Company’s calculation of fleet utilization may not be comparable to that reported by other companies.
   
(4) TCE rate is defined as the Company’s net vessel revenue less voyage expenses during a period divided by the number of the Company’s operating days during the period. Voyage expenses include port charges, bunker (fuel oil and diesel oil) expenses, canal charges and other commissions. The Company includes the TCE rate, which is not a recognized measure under U.S. GAAP, as it believes it provides additional meaningful information in conjunction with net revenues from vessels, the most directly comparable U.S. GAAP measure, and because it assists the Company’s management in making decisions regarding the deployment and use of our vessels and because the Company believes that it provides useful information to investors regarding our financial performance. The Company’s calculation of TCE rate may not be comparable to that reported by other companies. The following table reconciles the Company’s net revenues from vessels to the TCE rate.
   

(In thousands of U.S. Dollars, except operating days and TCE rate)

  Q3 2026 Q3 2025 9M 2026 9M 2025
Vessel revenue, net 56,800 46,126 153,544 106,466
Less: Voyage expenses 809 2,555 2,767 4,402
Time charter equivalent revenues 55,991 43,571 150,777 102,064
Operating days 1,634 1,856 4,990 5,363
TCE rate $34,266 $23,476 $30,216 $19,031

(5) Vessel operating expenses include crew costs, provisions, deck and engine stores, lubricants, insurance, maintenance and repairs. Daily Vessel Operating Expenses are calculated by dividing vessel operating expenses, excluding pre delivery costs, by ownership days for the relevant time periods. The Company’s calculation of daily vessel operating expenses may not be comparable to that reported by other companies. The following table reconciles the Company’s vessel operating expenses to daily vessel operating expenses.
   

(In thousands of U.S. Dollars, except ownership days and Daily Vessel Operating Expenses)

  Q3 2026 Q3 2025 9M 2026 9M 2025
Vessel operating expenses 11,094 14,095 35,800 40,441
Less: Pre-delivery expenses – – – 757
Vessel operating expenses before pre-delivery expenses 11,094 14,095 35,800 39,684
Ownership days 1,656 1,911 5,115 5,600
Daily Vessel Operating Expenses $6,699 $7,376 $6,999 $7,086
         

Net income to EBITDA and Adjusted EBITDA Reconciliation:

(In thousands of U.S. Dollars)

  Q3 2026   Q3 2025   9M 2026   9M 2025  
Net income 25,965   12,752   61,859   8,785  
Interest and finance cost, net 4,141   5,378   12,280   15,943  
Depreciation and amortization 9,280   9,415   28,077   26,792  
EBITDA 39,386   27,545   102,216   51,520  
Stock based compensation 1,648   1,026   6,166   3,703  
Loss on extinguishment of debt 417   63   2,589   91  
Loss on forward freight agreements, net 16   35   26   54  
(Gain) / loss on FX derivatives (20 ) 192   94   (231 )
Unrealized gain on equity securities (36 ) –   (36 ) –  
Unrealized FX gain on unsecured bond (600 ) –   (600 ) –  
Adjusted EBITDA 40,811   28,861   110,455   55,137  


Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”) represents the sum of net income, net interest and finance costs, depreciation and amortization and, if any, income taxes during a period. EBITDA and Adjusted EBITDA are not recognized measurements under U.S. GAAP. Adjusted EBITDA represents EBITDA adjusted to exclude stock-based compensation, loss on forward freight agreements, net, loss on extinguishment of debt, (gain) / loss on FX derivatives, unrealized gain on equity securities and unrealized FX gain on unsecured bond which the Company believes are not indicative of the ongoing performance of its core operations.

EBITDA and adjusted EBITDA are presented as we believe that these measures are useful to investors as a widely used means of evaluating operating profitability from period to period. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating the Company’s performance. EBITDA and adjusted EBITDA as presented here may not be comparable to similarly titled measures presented by other companies. These non-GAAP measures should not be considered in isolation from, as a substitute for, or superior to, financial measures prepared in accordance with U.S. GAAP.

Adjusted Net Income Reconciliation and calculation of Adjusted Earnings Per Share

(In thousands of U.S. Dollars, except for share and per share data)

  Q3 2026   Q3 2025   9M 2026   9M 2025  
Net income 25,965   12,752   61,859   8,785  
Stock based compensation 1,648   1,026   6,166   3,703  
Loss on extinguishment of debt (non-cash) 83   63   1,524   81  
(Gain) / loss on FX derivatives (20 ) 192   94   (231 )
Unrealized gain on equity securities (36 ) –   (36 ) –  
Unrealized FX gain on unsecured bond (600 ) –   (600 ) –  
Adjusted net income 27,040   14,033   69,007   12,338  
Dividends to non-vested participating securities (171 ) (25 ) (348 ) (91 )
Undistributed earnings to non-vested participating securities (416 ) (282 ) (984 ) (102 )
Adjusted net income – common shareholders 26,453   13,726   67,675   12,145  
Adjusted earnings per common share, basic 1.25   0.67   3.21   0.60  
Adjusted earnings per share, diluted 1.25   0.67   3.21   0.59  
Weighted average number of common shares outstanding, basic 21,177,455   20,493,231   21,072,954   20,336,137  
Weighted average number of common shares outstanding, diluted 21,177,455   20,562,616   21,072,954   20,425,195  


To derive Adjusted Net Income and Adjusted Earnings Per Share, a non-GAAP financial measure, from Net Income, we adjust for dividends and undistributed earnings to non-vested participating securities and exclude non-cash items, as provided in the table above. We believe that Adjusted Net Income and Adjusted Earnings Per Share assist our management and investors by increasing the comparability of our performance from period to period since each such measure eliminates the effects of such non-cash items as loss on extinguishment of debt, stock based compensation, (gain) / loss on FX derivatives, unrealized gain on equity securities, unrealized FX gain on unsecured bond and other items which may vary from year to year, for reasons unrelated to overall operating performance. In addition, we believe that the presentation of the respective measure provides investors with supplemental data relating to our results of operations, and therefore, with a more complete understanding of factors affecting our business than with GAAP measures alone. Our method of computing Adjusted Net Income and Adjusted Earnings Per Share may not necessarily be comparable to other similarly titled captions of other companies due to differences in methods of calculation.

Fourth Quarter 2026 TCE Rate Guidance:

As of the date hereof, approximately 86% of the Company fleet’s expected operating days in the fourth quarter of 2026 have been fixed at an estimated TCE rate of approximately $32,923. Assuming that for the remaining operating days of our index-linked time charters, the BCI-180 rate will be equal to $37,968 (based on the FFA curve as of November 5, 2026), our estimated TCE rate for the fourth quarter of 2026 will be approximately $33,2843. The following table provides the breakdown of index-linked charters and fixed-rate charters in the fourth quarter of 2026:

  Operating Days TCE
TCE – fixed rate (incl. FFA conversions) 1,195 $32,254
TCE – index-linked 435 $36,109
Total / Average 1,630 $
33,284

________________________
3
This guidance is based on certain assumptions and the Company cannot provide assurance that these TCE rate estimates, or projected utilization rates will be realized. TCE estimates include certain floating (index) to fixed rate conversions concluded in previous periods. For vessels on index-linked T/Cs, the TCE rate realized will vary with the underlying index, and for the purposes of this guidance, the BCI 5TC 180 rate assumed for the remaining operating days of the quarter for index-linked T/Cs is equal to $37,968 (based on the FFA curve as of November 5, 2026). Spot estimates are provided using the load-to-discharge method of accounting. The rates quoted are for days currently contracted. Increased ballast days at the end of the quarter will reduce the additional revenues that can be booked based on the accounting cut-offs and therefore the resulting TCE rate will be reduced accordingly.



Third Quarter and Recent Developments:


Dividend Distribution for Q2 2026 and Declaration of Q3 2026 Dividend

On October 9, 2026, the Company paid a quarterly cash dividend of $0.35 per common share for the second quarter of 2026 to all shareholders of record as of September 25, 2026.

The Company has declared a quarterly cash dividend of $0.40 per common share for the third quarter of 2026 payable on or about January 8, 2027, to all shareholders of record as of December 24, 2026.


Fleet Update

Acquisition of Four Vessels for Delivery Between 2027 and 2029

Since its previous quarterly update, the Company has agreed to acquire four vessels from unaffiliated third parties for an aggregate consideration of approximately $264 million, comprising:

  • a 180,000 dwt Capesize built in 2019 in Japan, to be renamed M/V Midnightship, expected to be delivered in January 2027 and to be funded through cash on hand and debt financing;
  • a 210,000 dwt scrubber-fitted Newcastlemax newbuilding, contracted in July 2026 with Hengli Shipbuilding (Dalian) Co., Ltd. and Hengli Shipbuilding (Singapore) Pte. Ltd., with delivery expected in the first quarter of 2029;
  • a 181,000 dwt scrubber-fitted Capesize newbuilding at a Japanese shipyard, with delivery expected in the second half of 2029; and
  • a 210,000 dwt Newcastlemax built in 2014 in Japan, with delivery expected in the second half of 2029.

For the 2019-built Capesize, the Company has paid a 10% deposit, with the remaining 90% payable upon delivery. The contract price of the Hengli newbuilding is payable in five instalments linked to construction milestones, with 60% payable upon delivery. For the Japanese Capesize newbuilding, the Company has paid the first instalment of the purchase price, with 35% payable in three instalments linked to construction milestones and 60% payable upon delivery. For the 2014-built Newcastlemax, the agreement provides for a 10% deposit, with the remaining 90% payable upon delivery.

The newbuildings will incorporate eco-design features, enhancing fuel efficiency and reducing emissions in line with the Company’s fleet renewal and decarbonization strategy.

Advances Towards the Ship Investment Program

Including the four additional vessels, the Company’s total investment program currently stands at $855 million. To date, the Company has paid $127.4 million towards its fleet investment program. The remaining commitments of approximately $727.6 million are staggered through 2029, with the largest instalments payable upon delivery of the respective vessels, and are expected to be funded through a combination of existing liquidity, including cash and restricted cash of $167.9 million as of September 30, 2026, operating cash flow, committed and future vessel financing and proceeds from selective vessel disposals.

Sale of M/V Friendship

In November 2026, the Company agreed on the main terms to sell the M/V Friendship to United Maritime Corporation (“United”), a related party, for an aggregate purchase price of $33.0 million. The sale is subject to the existing financier’s approval and the parties entering into final documentation, with delivery expected in early Q1 2027. A special committee of independent and disinterested members of the Company’s board of directors negotiated and approved the terms.

The transaction is expected to generate net cash proceeds of approximately $19.6 million, supporting the Company’s ongoing fleet renewal program, while reducing Seanergy’s average fleet age. The sale is also expected to result in a book gain of approximately $12.4 million, to be recognized upon delivery of the vessel in the first quarter of 2027. Following delivery, Seanergy will continue to provide technical and commercial management services to the vessel.


Commercial Updates

M/V Premiership – Time Charter Extension

In September 2026, the time charter agreement for the M/V Premiership was extended until minimum January 2028 and maximum March 2028, in direct continuation from the previous agreement. The revised daily hire is based on the 5 T/C routes of the BCI, while all other main terms of the time charter remain materially the same.

M/V Patriotship – Time Charter Extension

In November 2026, the time charter agreement for M/V Patriotship was extended until minimum January 2028 and maximum March 2028, in direct continuation from the previous agreement. The revised daily hire is based on the 5 T/C routes of the BCI, with retroactive effect from January 2026, while all other main terms of the time charter remain materially the same.


Conference Call

:

The Company’s management will host a conference call to discuss financial results on November 12, 2026, at 10:00 a.m. Eastern Time.


Audio Webcast:

There will be a live, and then archived, webcast of the conference call available through the Company’s website. To listen to the archived audio file, visit our website, following the Webcast & Presentations section under our Investor Relations page. Participants to the live webcast should register on Seanergy’s website approximately 10 minutes prior to the start of the webcast, following this link.


Conference Call Details

:

Participants have the option to register for the call using the following link. You can use any number from the list or add your phone number and let the system call you right away.

             
Seanergy Maritime Holdings Corp.

Unaudited Condensed Consolidated Balance Sheets
(In thousands of U.S. Dollars)
             
    September 30,
2026
    December 31,
2025*
 
ASSETS            
Cash and cash equivalents and restricted cash   167,944     62,653  
Vessels, net, vessels under construction, advances for vessel acquisition, finance lease prepayment and sales type leases   575,674     506,660  
Other assets   38,277     37,266  
TOTAL ASSETS   781,895     606,579  
             
LIABILITIES AND STOCKHOLDERS’ EQUITY            
Long-term debt and other financial liabilities, net of deferred finance costs   409,726     290,160  
Other liabilities   39,030     35,036  
Stockholders’ equity   333,139     281,383  
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   781,895     606,579  

* Derived from the audited consolidated financial statements as of that date

           
Seanergy Maritime Holdings Corp.

Unaudited Condensed Consolidated Statements of Operations
(In thousands of U.S. Dollars, except for share and per share data, unless otherwise stated)
           
    Three months ended
September 30,
  Nine months ended
September 30,
 
    2026   2025   2026     2025  
Vessel revenue, net   56,800   46,126   153,544     106,466  
Fees from related parties   652   866   1,701     2,211  
Revenue, net   57,452   46,992   155,245     108,677  
Expenses:                    
Voyage expenses   (809 ) (2,555 ) (2,767 )   (4,402 )
Vessel operating expenses   (11,094 ) (14,095 ) (35,800 )   (40,441 )
Management fees   (225 ) (279 ) (745 )   (831 )
General and administrative expenses   (6,187 ) (4,629 ) (20,352 )   (13,641 )
Depreciation and amortization   (9,280 ) (9,415 ) (28,077 )   (26,792 )
Gain on sales type leases   –   –   4,101     –  
Gain on sale of vessel   –   2,308   4,559     2,308  
Loss on forward freight agreements, net   (16 ) (35 ) (26 )   (54 )
Operating income   29,841   18,292   76,138     24,824  
Other income / (expenses):                    
Interest and finance costs   (5,114 ) (5,566 ) (14,253 )   (16,496 )
Loss on extinguishment of debt   (417 ) (63 ) (2,589 )   (91 )
Interest and other income   837   193   1,570     530  
Interest and other income – related party   182   –   464     48  
Other, net   636   (104 ) 529     (30 )
Total other expenses, net:   (3,876 ) (5,540 ) (14,279 )   (16,039 )
Net income   25,965   12,752   61,859     8,785  
Net income attributable to common shareholders   25,378   12,445   60,527     8,592  
                     
Net income per common share, basic and diluted   1.20   0.61   2.87     0.42  
Weighted average number of common shares outstanding, basic   21,177,455   20,493,231   21,072,954     20,336,137  
Weighted average number of common shares outstanding, diluted   21,177,455   20,562,616   21,072,954     20,425,195  
                     

       
Seanergy Maritime Holdings Corp.

Unaudited Condensed Consolidated Cash Flow Data
(In thousands of U.S. Dollars)
       
    Nine months ended
September 30,
 
    2026   2025  
Net cash provided by operating activities   82,219   25,819  
           
Vessels acquisitions and improvements   (3,029 ) (34,401 )
Advance for vessel acquisition   (4,950 ) –  
Vessels under construction   (102,170 ) –  
Loan to related party   –   (2,000 )
Repayment of loan by related party   –   2,000  
Finance lease prepayments and other initial direct costs   (3,883 ) (8,150 )
Investment in equity securities   (924 ) –  
Proceeds from sale of assets   13,813   21,590  
Due from related parties   2,466   (188 )
Net cash used in investing activities   (98,677 ) (21,149 )
           
Proceeds from long-term debt and other financial liabilities   255,100   110,560  
Repayments of long-term debt and other financial liabilities   (114,184 ) (80,120 )
Payments of financing and stock issuance costs   (8,760 ) (2,045 )
Payments of finance lease liabilities   –   (23,747 )
Proceeds from other non-current liabilities   1,004   166  
Dividends payments   (11,412 ) (8,433 )
Proceeds from issuance of common stocks and warrants, net of underwriters fees and commissions   –   845  
Net cash provided by / (used in) financing activities   121,748   (2,774 )
           
SUPPLEMENTAL CASH FLOW INFORMATION          
Cash paid during the period for interest, net of capitalized interest   9,509   15,893  
           
Noncash investing activities          
Vessels’ improvements   810   263  
Other financial liabilities assumed by buyer upon sale of vessel   15,687   –  
Vessels under construction   532   –  
           
Noncash financing activities          
Dividends declared but not paid   7,584   1,056  
Financing and stock issuance costs   2,013   78  
Other financial liabilities assumed by buyer upon sale of vessel   (15,687 ) –  
           

About Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp. is a prominent pure-play Capesize shipping company publicly listed in the U.S. Seanergy provides marine dry bulk transportation services through a modern fleet of Capesize vessels. The Company owns or operates under finance leases 19 vessels (2 Newcastlemax and 17 Capesize) with an average age of approximately 15.3 years and an aggregate cargo carrying capacity of 3,463,843 dwt. Upon the sale of the M/Vs Dukeship and Friendship and the delivery of the nine newbuilding vessels and three secondhand vessels, the Company will own or operate under finance leases 29 vessels (5 Newcastlemax and 24 Capesize), with an aggregate cargo carrying capacity of approximately 5,367,438 dwt.

The Company is incorporated in the Republic of the Marshall Islands and has executive offices in Glyfada, Greece. The Company’s common shares trade on the Nasdaq Capital Market under the symbol “SHIP”.

Please visit our Company website at: www.seanergymaritime.com.

Forward-Looking Statements

This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events, including with respect to declaration of dividends, market trends and shareholder returns. Words such as “may”, “should”, “expects”, “intends”, “plans”, “believes”, “anticipates”, “hopes”, “estimates” and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company’s operating or financial results; the Company’s liquidity, including its ability to service its indebtedness; competitive factors in the market in which the Company operates; shipping industry trends, including charter rates, vessel values and factors affecting vessel supply and demand; future, pending or recent acquisitions and dispositions, business strategy, impacts of litigation, areas of possible expansion or contraction, and expected capital spending or operating expenses; risks associated with operations outside the United States; risks arising from trade disputes between the U.S. and China, including the re-imposition of reciprocal port fees; broader market impacts arising from trade disputes or war (or threatened war) or international hostilities, such as between the U.S. and Israel and Iran, the U.S. and Venezuela, China and Taiwan and Russia and Ukraine; risks associated with the length and severity of pandemics; and other factors listed from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (“SEC”), including its most recent annual report on Form 20-F. The Company’s filings can be obtained free of charge on the SEC’s website at www.sec.gov. Except to the extent required by law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

For further information please contact:

Seanergy Investor Relations
Tel: +30 213 0181 522
E-mail: [email protected]

Capital Link, Inc.
Paul Lampoutis
230 Park Avenue Suite 1540
New York, NY 10169
Tel: +1 212 661 7566
E-mail: [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/faee33af-960d-4b38-a5b5-039cbf064d45



Motion Recruitment’s 2027 Tech Salary Guide Finds Modest Overall Pay Growth, Double-Digit Gains in Specialized Roles as Emerging Tech Reshapes Talent Market

Analysis shows IT salaries rising 2.1% year over year with demand driven by employers in healthcare, manufacturing, government and financial services

Facts at a Glance:

  • In-demand roles such as Senior Cybersecurity Architect saw salary increases of up to 22% year over year.
  • Most tech workers are now employed at non-tech companies.
  • The median tech wage is 126% higher than the national average.

TROY, Mich., Nov. 12, 2026 (GLOBE NEWSWIRE) — Technology staffing and solutions leader Motion Recruitment, a Kelly® (Nasdaq: KELYA, KELYB) company, has published its 2027 Tech Salary Guide, offering workforce trends and compensation data for the most in-demand IT roles. The guide finds that tech salaries have increased 2.1% year over year, with stronger gains in specialized roles, as today’s technology labor market is increasingly shaped by AI investment, shifting skill requirements and demand beyond traditional tech companies.

The tenth annual report analyzes thousands of job postings and real-time market data. It features insights from industry leaders to help employers and job seekers separate what is driving the market from what is making headlines.

Tech Pay Rises Modestly as Demand Shifts Beyond Tech Companies

Average tech salaries in the United States rose 2.1%, according to Motion’s analysis, but salary increases vary sharply by specialty and region:

  • Senior Cybersecurity Architects saw a 22% year-over-year increase, while Network Security Engineers averaged 14% growth and Application Developers saw an average of 10% growth. AI Engineers saw an average increase of 8%.
  • Salary increases differed across regions, with Atlanta (12%), Dallas (11%), Charlotte (10%) and Phoenix (10%) seeing some of the largest percentage annual gains.

“AI and emerging technologies are changing the mix of specialized expertise companies need, from software and data to cybersecurity, cloud and infrastructure,” said Motion Recruitment President James Vallone. “For employers, the strategic challenge is connecting those capabilities to turn investment into reliable, scalable systems. That means planning beyond your next hire to identify the skills, team structure and project delivery support needed to move from experimentation to execution.”

These compensation trends sit within an IT workforce that extends well beyond tech companies. Only about 40% of tech workers are employed directly by technology companies, with healthcare, manufacturing, government and financial services now employing the majority of tech workers. Hiring signals inside and outside the tech industry are pointing in different directions:

  • Tech companies cut more than 122,000 jobs through mid-2026, and employment within the tech industry has declined for 16 consecutive months.
  • However, net tech employment is projected at 9.8 million, up 200,000 from the previous year.
  • IT job postings grew from fewer than 380,000 in January to more than 629,000 in October.

AI-Driven Layoffs Face Growing Scrutiny

Early assumptions about AI replacing workers are being reconsidered. A Morning Consult survey commissioned by Kelly found only 10% of employers are cutting headcount because of AI, while 39% are redistributing tasks and 20% are adding staff. Other research highlights the challenges:

  • 55% of employers now say they regret decisions around AI-related layoffs.
  • Half of companies that cited AI for headcount reductions are projected to rehire for similar functions by 2027, though often under offshore roles, new titles or lower-level positions.
  • Only 7% of business leaders report having established ROI from their AI investments.

“Employers need to assess not only what AI can do, but also the infrastructure, oversight and skills needed to make it effective,” Vallone said. “Before making workforce decisions, IT leaders should be clear about what they expect AI to deliver, who is accountable for the results and where human expertise remains essential. AI is a force multiplier, not a one-to-one replacement.”

AI Fluency Becomes a Baseline While the Entry-Level Ladder Narrows

Employers now require AI competency for over one third of entry-level jobs. Early-career professionals face a difficult combination of higher AI skill expectations with fewer opportunities to build applied experience on the job.

  • 75% of U.S. tech job postings require AI skills.
  • Active listings for roles requiring AI capabilities grew from nearly 275,000 in January to more than 366,000 in October.
  • 35% of entry-level jobs now require AI competency.

Meanwhile, employers and talent disagree on the level of AI training provided. The Kelly survey found 44% of employers say they did a great deal to train employees on AI, while 50% of employed workers say their company has done nothing. AI is also complicating how employers screen candidates, with a recent survey finding 40% of hiring managers have interviewed a candidate later revealed to be using a fake identity.

“Employers want people who can contribute quickly, but they also need to build the talent they’ll depend on next,” Vallone said. “Early-career candidates who can explain, test and improve what they built with AI deserve a closer look. The challenge is creating room to develop sound technical judgment, even as teams face pressure to do more with less.”

AI Demand Creates a Chain Reaction Across Emerging Tech and Infrastructure

AI adoption is driving demand for specialized talent beyond AI itself, including cloud, semiconductors, data centers and power infrastructure. Organizations report being understaffed in AI (47%), cybersecurity (40%) and platform engineering (34%), while 61% of organizations report inadequate quantum skills. The U.S. also faces a projected shortage of up to 157,000 semiconductor workers by 2030. As AI investment accelerates, these interconnected talent gaps present a growing challenge.

The 2027 Tech Salary Guide offers employers and tech professionals a comprehensive look at market trends, emerging specialties and compensation data alongside practical hiring and career advice. To explore the full report, access the 2027 Tech Salary Guide here.

About Motion’s 2027 Tech Salary Guide

Motion Recruitment’s 2027 Tech Salary Guide provides compensation data, market insights and expert advice to support workforce planning, budget alignment and career development. The guide is built from Motion’s proprietary data, verified job placements and employer demand trends, supplemented by third-party research and real-time labor market intelligence across the United States.

About Motion Recruitment

Motion Recruitment, a Kelly® company, helps organizations accelerate their most important technology initiatives through specialized talent, consulting and project-based solutions. As the leader of Kelly’s technology division, Motion connects companies with hard-to-find expertise across software, data, AI, cloud, product, cybersecurity and other high-demand technology disciplines, delivering flexible solutions that range from contract staffing and direct hire to project and program delivery. Through Motion Consulting Group, clients can go beyond traditional staffing to access strategic consulting, digital transformation, and outcome-based solutions. Motion is also the creator of Tech in Motion, a North American technology networking and awards program connecting more than 350,000 tech enthusiasts. As part of Kelly’s evolving specialty portfolio, Motion Recruitment and Motion Consulting Group will come together under Kelly Technology in 2027.

About Kelly

®

At Kelly® (Nasdaq: KELYA, KELYB), we don’t just understand the future of work, we’re defining it. For over 80 years, we’ve sourced specialized talent, built agile workforces, and shaped growth strategies for employers around the world. Today, our recruiting, outsourcing, and consulting services provide the talent and solutions organizations need to move faster and grow smarter. We deliver meaningful impact by connecting people to work that enriches their lives, and companies to people who drive innovation and growth. Each year, we place more than 375,000 job seekers in new roles spanning science, engineering, technology, telecom, education, manufacturing, and more.

Media Contact

Christian Taske
248-561-8823
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f202c771-a7e2-434e-9bf0-c17ef5aedd73

This press release was published by a CLEAR® Verified individual.



Moleculin Secures Australian Patent for Annamycin Formulation Technology

Patent strengthens intellectual property protection for preparation of preliposomal Annamycin lyophilizate

HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc. (Nasdaq: MBRX) (“Moleculin” or the “Company”) today announced the grant of an Australian patent covering the preparation of preliposomal Annamycin lyophilizate, strengthening the Company’s intellectual property protection for a key aspect of Annamycin’s formulation technology.

Australian Patent No. 2020303572 was granted to Moleculin and The Board of Regents of The University of Texas System. The patent titled, “Preparation of Preliposomal Annamycin Lyophilizate,” addresses the preparation of Annamycin’s formulation.

“Securing this patent in Australia represents another step in our efforts to build a strong international intellectual property position around Annamycin,” said Walter Klemp, Chairman and Chief Executive Officer of Moleculin. “Our formulation technology is an important component of Annamycin’s development, and protecting this technology across international markets supports our broader intellectual property strategy.”

Expanding International Protection for Annamycin Formulation Technology

The Australian patent is part of Moleculin’s broader global intellectual property portfolio covering complementary technologies associated with Annamycin, the Company’s investigational anthracycline.

The patent portfolio includes granted or allowed patents in the United States, Canada, China, Europe, India, Israel, Japan, Mexico, Singapore and Taiwan. The application has also been accepted in South Africa, where formal grant is pending, while applications remain pending in additional jurisdictions, including South Korea.

Moleculin’s global patent strategy also encompasses additional technology areas, including methods for reconstituting liposomal Annamycin and lung-targeted anticancer therapies using liposomal Annamycin. Together, these efforts reflect the Company’s focus on establishing intellectual property protection across multiple aspects of Annamycin’s development and in key international markets.

Annamycin is an investigational anthracycline designed to address limitations associated with conventional anthracyclines. The drug candidate is being evaluated in clinical development for acute myeloid leukemia (AML) and other difficult-to-treat cancers.

About Moleculin Biotech, Inc.

Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses. The Company’s lead program, Annamycin (also known as naxtarubicin), has shown to be an efficacious and well tolerated anthracycline designed to avoid multidrug resistance mechanisms and to lack the cardiotoxicity common with currently prescribed anthracyclines. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.

The Company is conducting the MIRACLE (Moleculin R/R AML AnnAraC Clinical Evaluation) Trial (MB-108), a pivotal, adaptive design, multi-center, randomized, double-blind, placebo-controlled Phase 2/3 trial evaluating Annamycin in combination with cytarabine (also referred to as “Ara-C”), together referred to as AnnAraC, for the treatment of relapsed or refractory acute myeloid leukemia. Following a successful Phase 1B/2 study (MB-106), with input from the FDA, the Company believes it has substantially de-risked the development pathway toward a potential approval for Annamycin for the treatment of AML. This study remains subject to appropriate future filings with potential additional feedback from the FDA and their foreign equivalents.

Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers. Moleculin also has in its pipeline a portfolio of antimetabolites, including WP1122 for the potential treatment of pathogenic viruses, as well as certain cancer indications.

For more information about the Company, please visit www.moleculin.com and connect on X, LinkedIn and Facebook.

Forward-Looking Statements

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the potential efficacy and safety of Annamycin and AnnAraC in R/R AML, the strength and scope of the Company’s intellectual property portfolio, the Company’s ability to obtain and enforce patent protection in various jurisdictions, and the anticipated advancement of the MIRACLE trial toward potential registration. Moleculin will require significant additional financing, for which the Company has no commitments, in order to conduct its clinical trials as described in this press release, and the ability to complete such trials assumes the Company’s ability to secure such financing on a timely basis. Although Moleculin believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company relies on the reports of its expert with regard to the absence of cardiotoxicity. Moleculin has attempted to identify forward-looking statements by terminology including ‘believes,’ ‘estimates,’ ‘anticipates,’ ‘expects,’ ‘plans,’ ‘projects,’ ‘intends,’ ‘potential,’ ‘may,’ ‘could,’ ‘might,’ ‘will,’ ‘should,’ ‘approximately’ or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. “Risk Factors” in our most recently filed Form 10-K filed with the Securities and Exchange Commission (SEC) and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. We undertake no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Investor Contact:

JTC Team, LLC
Jenene Thomas
(908) 824-0775
[email protected]



High Roller Technologies Inks Agreement with ProphetX to Expand Event Contracts Offering Through ROLR™

Planned integration intends to enable eligible ROLR customers to access ProphetX’s sports-focused exchange, supporting broader market choice and additional revenue opportunities

LAS VEGAS, Nevada, Nov. 12, 2026 (GLOBE NEWSWIRE) — High Roller Technologies, Inc. (“High Roller” or the “Company”) (NYSE: ROLR), an online gaming and prediction markets company, today announced that its wholly owned subsidiary, ROLR FCM LLC, has entered into a definitive commercial agreement with ProphetX LLC (“ProphetX”) to integrate access to ProphetX’s federally regulated prediction markets exchange through a ROLR-branded interface.

“Expanding the markets available through ROLR is an important part of building a platform that traders choose to engage with,” said Seth Young, Chief Executive Officer of High Roller. “Our agreement with ProphetX combines additional sports markets with a revenue-sharing structure that allows ROLR to earn a portion of net fees generated by traders accessing ProphetX’s exchange through our interface. We believe this creates an attractive opportunity to generate an additional revenue stream by building on the ROLR brand, customer experience and marketing capabilities as we grow the business.”

“ROLR is building a prediction markets business around its brand, customer experience and distribution capabilities,” said Jake Benzaquen, Co-Founder and Chief Commercial Officer of ProphetX. “Our infrastructure gives partners a way to bring our event contracts directly into their products, while ProphetX handles the exchange and clearing functions. We look forward to working with High Roller to extend access to our markets through ROLR.”

Agreement and Integration Highlights

  • Expanded sports markets: The planned integration is intended to give eligible ROLR customers access to additional sports event contracts on ProphetX, whose markets cover outcomes such as game results, player performance and season-long championships. Participants trade with one another at prices determined by buying and selling activity.
  • ROLR-branded experience: Eligible users would be able to view ProphetX market data, submit orders electronically for execution on ProphetX’s exchange, and access and manage their ProphetX trading accounts through a ROLR-branded interface.
  • Regulated exchange infrastructure: ProphetX is registered with the Commodity Futures Trading Commission (the “CFTC”) as both a designated contract market and a derivatives clearing organization, providing the infrastructure for trading, clearing and settlement.
  • Defined operating responsibilities: ROLR would manage branding, marketing, customer acquisition and interface distribution. ProphetX would maintain customer trading accounts and funds and handle onboarding, identity verification, trade execution, clearing, settlement and market surveillance. Trading would remain subject to ProphetX’s rules and eligibility requirements.
  • Revenue participation: ROLR would receive a share of net fees generated by users accessing ProphetX through the ROLR-branded interface, creating an additional potential revenue source.
  • Nonexclusive relationship: The agreement provides flexibility for ROLR to continue expanding its offering through connections to other exchanges, subject to the agreement’s terms.
  • Timing and availability: The agreement provides for an effective date six months after ROLR FCM LLC receives registration as a futures commission merchant, unless the parties mutually agree otherwise. ROLR FCM LLC has not yet received such registration, and there can be no assurance as to whether or when it will be obtained. Commercial availability will depend on completion of the integration, operational readiness and satisfaction of applicable regulatory requirements. A launch date has not been announced.


I


mportant Information

ROLR FCM LLC is not currently registered as a futures commission merchant with the CFTC or a member of the National Futures Association, and the integration described in this press release will not be made available unless and until all applicable registrations, approvals and conditions have been obtained or satisfied. Access to event contracts will be subject to ProphetX’s rules and eligibility requirements and to applicable law, and may not be available to all persons or in all jurisdictions. Trading event contracts involves substantial risk, including the risk of loss of the entire amount committed to a position, and is not suitable for all participants

About High Roller Technologies, Inc.

High Roller Technologies, Inc. (NYSE: ROLR) is a publicly traded online gaming and prediction markets company, known for its innovative casino brands High Roller and Fruta, and its prediction markets brand, ROLR. The Company delivers cutting-edge real-money consumer facing products that are intuitive and user-friendly. With a diverse portfolio of over 6,000 premium online casino games from more than 90 leading game providers, High Roller Technologies offers an immersive and engaging gaming experience in the rapidly expanding multi-billion-dollar iGaming industry. As an award-winning operator, High Roller Technologies continues to redefine the future of market engagement through innovation, performance, and a commitment to excellence.

For more information, please visit the Company’s investor relations website and follow High Roller Technologies on X, Facebook, and LinkedIn.

About ProphetX

Founded in 2018, ProphetX operates a U.S. prediction markets exchange and clearing organization registered with the CFTC. Built on a sports-focused foundation, its marketplace enables participants to trade event-based contracts at prices determined by market participants. ProphetX also provides infrastructure that enables other consumer platforms to integrate access to its markets. Its capabilities include a request-for-quote mechanism for pricing multi-event combinations. For more information, visit http://www.prophetx.co/partners.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions, the commercial launch and growth of the ROLR™ prediction markets platform, the anticipated integration with ProphetX, the expected effective date and terms of the agreement with ProphetX, the anticipated receipt of futures commission merchant registration by ROLR FCM LLC. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, our limited operating history in the prediction markets business; the ability of ROLR FCM LLC to obtain and maintain registration as a futures commission merchant and membership in the National Futures Association, and the timing thereof; the ability of the parties to complete the integration with ProphetX on the anticipated timeline or at all, and the risk that the agreement with ProphetX is terminated, modified or does not produce the anticipated revenue or other benefits; the nonexclusive nature of the agreement with ProphetX and competition from other platforms and exchanges; risks related to platform stability, scalability and technical performance, our ability to attract, convert and retain platform users and to generate revenue from the platform in the anticipated timeline or at all, the effectiveness of and cost of our marketing and customer-acquisition efforts and the performance of our marketing and distribution partners; our reliance on third parties, including Crypto.com | Derivatives North America, Crypto.com FCM and mrkts.com, and the continuation of our guarantee, license and development agreements; our ability to maintain the registration of ROLR US LLC as a guaranteed introducing broker and its membership in the National Futures Association, the evolving regulatory environment applicable to prediction markets and event-based contracts, and general market and economic conditions and such factors as discussed throughout Part I, Item 1A. Risk Factors and Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2025, Part I. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors, of our quarterly report on Form 10-Q/A for the quarter ended June 30, 2026 and in our other filings with the Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contacts:

High Roller Investor Relations

[email protected]

800-460-1039

ProphetX

Jake Benzaquen

Co-Founder & CCO

[email protected]

http://www.prophetx.co/partners



CrowdStrike Named One of the World’s 25 Best Workplaces for Second Consecutive Year

CrowdStrike Named One of the World’s 25 Best Workplaces for Second Consecutive Year

97% of employees are proud to tell others they work at CrowdStrike, where a shared mission to stop breaches is powering the security and safety enterprises need to embrace AI

AUSTIN, Texas–(BUSINESS WIRE)–CrowdStrike (NASDAQ: CRWD) today announced it has been named one of Fortune’s World’s Best Workplaces™ in 2026 by Great Place To Work® and Fortune magazine for the second consecutive year. CrowdStrike is one of only 25 companies worldwide to earn the recognition. Together, the company’s more than 11,000 employees are delivering the security innovations that enable enterprises to move faster with AI without losing control, and to use AI to stop breaches.

“Security is the enabler, not the obstacle, for enterprise AI adoption, and there has never been a more consequential time to work in cybersecurity,” said J.C. Herrera, chief human resources officer at CrowdStrike. “Our people are solving problems that have never been solved before, challenging what’s possible, and building technology that changes how the world is protected. That ambition, united by a shared mission to stop breaches, is what makes our culture one of the world’s best.”

Global Recognition for a Culture of Innovation and Impact

The Fortune World’s Best Workplaces™ list honors 25 companies that exemplify trust and leadership on a global scale. Winners were selected from more than 9 million employee survey responses representing 23 million employees worldwide.

A World-Class Culture Accelerating AI Security and Safety

CrowdStrike’s researchers, threat hunters, technologists, and security experts protect the systems that keep the world running. CrowdStrike’s frontline intelligence reveals how adversaries operate and fuels the innovations that keep defenders ahead. CrowdStrike pioneered AI Detection and Response (AIDR) with Falcon Guardian, giving enterprises the power to stop rogue AI agents and deploy AI faster with confidence. Through its Cyber Superintelligence Lab and SafeMind models, CrowdStrike delivers the first frontier AI purpose-built for defenders to stop the world’s most sophisticated adversaries.

Employee sentiment reflects this culture of pride and purpose:

  • 97% are proud to tell others they work at CrowdStrike.

  • 97% say when they joined the company, they were made to feel welcome.

  • 96% feel they are given a lot of responsibility.

  • 95% feel a sense of pride at what the company has accomplished.

The recognition adds to CrowdStrike’s growing list of global workplace accolades, including:

To join the mission to stop breaches, visit CrowdStrike Careers.

About CrowdStrike

CrowdStrike (NASDAQ: CRWD), a global cybersecurity leader, has redefined modern security with the world’s most advanced cloud-native platform for protecting critical areas of enterprise risk: endpoints and cloud workloads, identity, and data.

Powered by the CrowdStrike Security Cloud and world-class AI, the CrowdStrike Falcon® platform leverages real-time indicators of attack, threat intelligence, evolving adversary tradecraft, and enriched telemetry from across the enterprise to deliver hyper-accurate detections, automated protection and remediation, elite threat hunting, and prioritized observability of vulnerabilities.

Purpose-built in the cloud with a single lightweight-agent architecture, the Falcon platform delivers rapid and scalable deployment, superior protection and performance, reduced complexity, and immediate time-to-value.

CrowdStrike: We stop breaches.

Learn more: https://www.crowdstrike.com/

Follow us: Blog | X | LinkedIn | Instagram

Start a free trial today: https://www.crowdstrike.com/trial

© 2026 CrowdStrike, Inc. All rights reserved. CrowdStrike and CrowdStrike Falcon are marks owned by CrowdStrike, Inc. and are registered in the United States and other countries. CrowdStrike owns other trademarks and service marks and may use the brands of third parties to identify their products and services.

Media Contact

Jake Schuster

CrowdStrike Corporate Communications

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Software Networks Internet Artificial Intelligence Data Management Technology Online Privacy Security

MEDIA:

Logo
Logo

EHang Marks Sri Lanka’s First Human-Carrying eVTOL Flights, Advancing Its Global Fast Track Program

COLOMBO, Sri Lanka, Nov. 12, 2026 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Advanced Air Mobility (“AAM”) technology platform company, announced that its EH216-S pilotless electric vertical take-off and landing (“eVTOL”) aircraft completed Sri Lanka’s first human-carrying eVTOL flights in Colombo on November 11, which also marked the first such flights by Ehang pilotless eVTOL in South Asia. This milestone in the country’s advanced air mobility development advances EHang’s Global Fast Track Program in Sri Lanka from initial regulatory framework alignment to practical flight validation, laying the groundwork for future authorized commercial AAM operations.

(Photo: EH216-S conducts Sri Lanka’s first human-carrying eVTOL flight in Colombo)

The inaugural flight ceremony took place in Colombo, attended by senior government and aviation officials of Sri Lanka, led by Hon. Anura Karunathilaka, Minister of Ports and Civil Aviation of Sri Lanka; Hon. Janitha Ruwan Kodithuwakku, Deputy Minister of Ports and Civil Aviation; Capt. Daminda Rambukwella, Director General of Civil Aviation and Chief Executive Officer of the Civil Aviation Authority of Sri Lanka (“CAASL”); and Mr. Tang Yandi, Economic and Commercial Counsellor of the Embassy of the People’s Republic of China in Sri Lanka, alongside EHang executives including Conor Yang, Chief Financial Officer of EHang, and Xiaona Lee, China General Manager of EHang, as well as representatives from relevant government agencies, business partners, and members of the media.

Minister Karunathilaka and Deputy Minister Kodithuwakku were among the first guests to fly aboard the EH216-S, followed by W. W. S. Mangala, Secretary of the Ministry of Ports and Civil Aviation. The flights followed a scenic loop route along the coastline, giving guests a first-hand experience of the aircraft’s pilotless, safe and smooth operation. Commemorative flight tickets were also presented to mark this milestone in Sri Lanka’s AAM development.

 (Photo: Minister Karunathilaka and Deputy Minister Kodithuwakku experience a flight aboard EH216-S)

To date, EHang’s EH216 series eVTOL aircraft have completed nearly 100,000 safe flights, with Sri Lanka becoming the 24th country to join this growing global flight footprint.

(Photo: EH216-S conducts Sri Lanka’s first human-carrying eVTOL flight in Colombo)

Sri Lanka became the first country to adopt EHang’s Global Fast Track Program in August 2026. With the inaugural flights, the program has entered its flight validation phase. Going forward, EHang and its local partners will work with local regulators to conduct flight testing and operational validation, assessing aircraft performance and safety, generating operational data to inform regulatory reviews and subsequent approvals, and paving the way for future commercial operations.

(Photo: EH216-S conducts Sri Lanka’s first human-carrying eVTOL flight in Colombo)

Hon. Anura Karunathilaka, Minister of Ports and Civil Aviation of Sri Lanka, commented, “Having experienced the EH216-S firsthand, I was impressed by EHang’s technology and its progress in developing and operating autonomous eVTOL aircraft. We believe this technology has the potential to transform the future of aviation in our country, creating new opportunities in tourism, air taxi services, search and rescue operations and other applications. I congratulate EHang and all the partners and stakeholders whose cooperation has made this milestone possible. The Government remains committed to exploring the potential of this emerging technology for Sri Lanka.”

(Photo: Hon. Anura Karunathilaka, Minister of Ports and Civil Aviation of Sri Lanka delivers a speech at the event)

Capt. Daminda Rambukwella, Director General of Civil Aviation and Chief Executive Officer of CAASL, commented, “The event marks a historic milestone for Sri Lanka and an important moment for aviation in South Asia, as we introduce pilotless, human-carrying eVTOL technology to the country for the first time. This is an emerging technology that calls for new approaches to regulation and oversight as the global aviation industry continues to evolve. Through this program, we aim to build the necessary experience and frameworks to support its safe development and future operations.”

(Photo: Capt. Daminda Rambukwella, Director General of Civil Aviation and Chief Executive Officer of CAASL delivers a speech at the event)

Mr. Tang Yandi, Counsellor of the Embassy of the People’s Republic of China in Sri Lanka, commented, “As a leading Chinese company in the low-altitude economy, EHang is bringing the EH216-S pilotless human-carrying eVTOL aircraft to Sri Lanka, opening a new chapter in China-Sri Lanka cooperation in AAM. We extend warm congratulations on the launch of this project. Sri Lanka, with its beautiful landscape and distinctive island character, holds great promise for the low-altitude economy. Aerial sightseeing can add a new highlight to local tourism. Pilotless aerial vehicles can also play a valuable role in emergency rescue and the delivery of disaster-relief supplies, while offering flexible transport solutions for hard-to-reach areas such as islands and mountainous regions. We look forward to seeing the company continue to put safety first and uphold rigorous quality standards, so that the fruits of innovation better benefit the people of Sri Lanka.” 

(Photo: Mr. Tang Yandi, Counsellor of the Embassy of the People’s Republic of China in Sri Lanka)

Conor Yang, Chief Financial Officer of EHang, stated, “EHang’s Global Fast Track Program is a key pillar of our international market entry strategy, designed to bring not only our innovative pilotless eVTOL aircraft but also the broader ecosystem and operational capabilities needed to establish AAM services in local markets. It was a great honor to welcome the Minister, the Deputy Minister and the Secretary of the Ministry of Ports and Civil Aviation aboard the EH216-S, and we are grateful for their confidence in taking this first flight with us. Working closely with CAASL and our local partners, we are turning this approach into concrete progress on the ground, demonstrating our ability to build and deploy an integrated AAM ecosystem in international markets.”

Watch the video of the inaugural flight ceremony: https://www.ehang.com/video/show/664.html

About EHang

EHang (Nasdaq: EH) is the world’s leading Advanced Air Mobility technology platform company dedicated to making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang focuses on the research, development and manufacturing of a diversified portfolio of pilotless electric vertical take-off and landing (eVTOL) aerial vehicles, covering a wide range of application scenarios including aerial tourism, intra-city commuting, inter-city travel, logistics transportation and emergency firefighting. EHang’s flagship product, the EH216-S, has obtained the world’s first type certificate (TC), production certificate (PC) and standard airworthiness certificate (AC) for pilotless passenger-carrying eVTOL aircraft issued by the Civil Aviation Administration of China (CAAC), and has entered operation under China’s first batch of Air Operator Certificates (OC) for pilotless passenger-carrying eVTOL aircraft. In addition, the Company’s long-range VT35 model further extends inter-city mobility scenarios, laying the foundation for a multi-tiered low-altitude mobility network. Leveraging its advanced autonomous flight technology and scalable operational infrastructure, EHang is redefining the transportation of people and goods — transcending cities, regions and natural barriers to usher in a new era of air mobility. For more information, please visit www.ehang.com.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “may” and other similar expressions. Statements that are not historical facts, including statements regarding management’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Many factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to product certification, the Company’s expectations regarding demand for and market acceptance of its products, the commercialization of the Company’s unmanned aerial vehicle products and solutions and Advanced Air Mobility services, its relationships with strategic partners, its international deployment plans, regulatory sandbox initiatives, aircraft deployment, local operational approvals, the timing of flight validation and commercial operations in overseas markets, and the litigation currently involving the Company and potential litigation. The Company’s management has made such forward-looking statements based on current expectations, assumptions, estimates and projections. While the Company’s management believes that these expectations, assumptions, estimates and projections are reasonable, forward-looking statements are only predictions of future events and involve known and unknown risks and uncertainties that are difficult for the Company’s management to control. These risks and uncertainties may cause EHang’s actual results of operations, performance or achievements to differ materially from those expressed or implied by any forward-looking statements.

Media Contact: [email protected]

Investor Contact: [email protected]

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/24fc67cc-e765-44a8-a2ae-43792e78895a

https://www.globenewswire.com/NewsRoom/AttachmentNg/592b8479-b25c-4de7-8039-42c5bf6ce79a

https://www.globenewswire.com/NewsRoom/AttachmentNg/8f9cf833-1ba1-41ca-a0cc-f642a01430df

https://www.globenewswire.com/NewsRoom/AttachmentNg/37d1be40-8b4e-40a1-97b0-6b985facd6a6

https://www.globenewswire.com/NewsRoom/AttachmentNg/70610a61-2a15-47aa-8939-a3c79f84bb76 

https://www.globenewswire.com/NewsRoom/AttachmentNg/66f4736e-d979-49b6-a515-b260888e1a05

https://www.globenewswire.com/NewsRoom/AttachmentNg/bd442863-5f68-4160-b292-acc6c1bcb275

https://www.globenewswire.com/NewsRoom/AttachmentNg/6c71ce0d-dc01-4e8a-a91f-e55b20828c9b



Niagen Bioscience Expands HSA/FSA Payment Option for the Pharmaceutical-Grade Niagen™ At-Home Injection Kit through Niagen™ Plus

Niagen Bioscience Expands HSA/FSA Payment Option for the Pharmaceutical-Grade Niagen™ At-Home Injection Kit through Niagen™ Plus 

Qualified customers may now purchase the Niagen™ At-Home Injection Kit on www.niagenplus.com using HSA/FSA funds with Truemed

LOS ANGELES–(BUSINESS WIRE)–Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it has partnered with Truemed to provide qualified customers the option to purchase the Niagen™ At-Home Injection Kit using Health Savings Account (HSA) and Flexible Spending Account (FSA) funds, now available through its Niagen™ Plus telehealth platform. Qualified customers may use HSA/FSA funds to purchase the Niagen At-Home Injection Kit by selecting the Truemed (Pay with HSA/FSA) option at checkout.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112603360/en/

Qualified Customers may now purchase the Niagen™ At-Home Injection Kit on www.niagenplus.com using HSA/FSA funds with Truemed

Qualified Customers may now purchase the Niagen™ At-Home Injection Kit on www.niagenplus.com using HSA/FSA funds with Truemed

Rob Fried, CEO of Niagen Bioscience, remarked, “NAD+ injections are everywhere, but none are backed by published clinical research. We did the research on Niagen injections, and HSA/FSA eligibility puts our science-first approach within reach of more people.”

Pharmaceutical-grade injectable Niagen® (patented nicotinamide riboside chloride, or NRCl), the most efficient, well-researched, and high-quality NAD+ precursor brand available, is now accessible in ready-to-inject liquid and reconstituted powder formats, with qualified customers saving an average of 30% using HSA/FSA funds through Truemed.

The Company recently announced the publication of two open-label clinical trials on medRxiv evaluating subcutaneous (sub-q) and intramuscular (IM) Niagen injections. While NAD+ injections are increasingly popular, no published clinical trials have evaluated sub-q or IM NAD+ injections. In these trials, injectable Niagen was well tolerated, including over 90 days of at-home use, and exploratory, self-reported outcomes were associated with reduced fatigue and improved sleep and skin appearance. These findings require confirmation in larger, placebo-controlled studies (Nkrumah-Elie et al., 2026; Russ et al., 2026).

The Niagen Plus telehealth platform remains clinician-directed. Patients complete an online intake form, a licensed provider decides whether to prescribe, and if prescribed, the medication is dispensed from state-licensed 503A compounding pharmacies and shipped to their door. NiagenPlus.com is LegitScript Certified, an independent third-party certification for healthcare merchants and telehealth platforms.

The process is simple

  1. Find and click the Truemed logo during checkout.
  2. The Niagen Plus program is already eligible through Truemed, so the customer will go straight to the Truemed payment screen.
  3. After payment, the customer will return to Niagen Plus to complete their medical questionnaire. A licensed clinician will review their information, and if a prescription is not right for them, their purchase will be fully refunded.

To learn more and shop the Niagen At-Home Injection Kit now available for $199 with HSA/FSA funds, visit www.niagenplus.com and look for “Shop with HSA/FSA.” Truemed is for qualified customers. HSA/FSA tax savings vary. Learn more at truemed.com/disclosures.

For additional information on Niagen Plus, visit www.niagenplus.com.

About Niagen Bioscience

Niagen Bioscience, Inc. (NASDAQ: NAGE) is the global authority in healthy aging and NAD+ (nicotinamide adenine dinucleotide) science. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience™ is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions.

The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality.

Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There’s a better way to age.

At the heart of its clinically tested product portfolio is Niagen® (patented nicotinamide riboside, or NR), the most efficient, well-researched, and high-quality NAD+ booster available. Niagen powers the Company’s consumer supplement, Tru Niagen®, the number one NAD+ boosting oral supplement in the United States† (available at www.truniagen.com), and Niagen™ Plus, featuring pharmaceutical-grade intravenous (IV) and injectable Niagen products (www.niagenplus.com). Pharmaceutical-grade Niagen IV and injections are compounded and distributed by U.S. FDA-registered 503B outsourcing facilities and are available exclusively at clinics with a prescription. NAD Pharmaceuticals Corp., the Company’s wholly owned subsidiary focused on developing therapies for accelerated aging and rare genetic diseases, is conducting research on NB4168, a differentiated small molecule.

Niagen Bioscience’s robust patent portfolio protects NR and other NAD+ precursors. Niagen Bioscience maintains a website at www.niagenbioscience.com, where copies of press releases, news, and financial information are regularly published.

Forward-Looking Statements:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as “expects,” “anticipates,” “intends” “estimates,” “plans,” “potential,” “possible,” “probable,” “believes,” “seeks,” “may,” “will,” “should,” “could,” “predicts,” “projects,” “continue,” “would” or the negative of such terms or other similar expressions.

Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those described. These risks and uncertainties include, but are not limited to, statements regarding the availability of HSA/FSA funds for our products, which depends on IRS rules and plan administrator determinations; our reliance on third-party payment and telehealth partners; regulation of telehealth and 503A pharmacy compounding; inflationary conditions and adverse economic conditions; our history of operating losses; the growth and profitability of our product sales; our ability to maintain and grow sales, marketing and distribution capabilities; changing consumer perceptions of our products; our reliance on a single or limited number of third-party suppliers; risks of conducting business in China; including unanticipated developments in and risks related to the Company’s ability to secure adequate quantities of pharmaceutical-grade Niagen in a timely manner; the Company’s ability to obtain appropriate contracts and arrangements with U.S. FDA-registered 503B outsourcing facilities required to compound and distribute pharmaceutical-grade Niagen to clinics; the Company’s ability to remain on the U.S. FDA Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Category 1 list; the Company’s ability to maintain and enforce the Company’s existing intellectual property and obtain new patents; whether the potential benefits of NRC can be further supported; further research and development and the results of clinical trials possibly being unsuccessful or insufficient to meet applicable regulatory standards or warrant continued development; the ability to enroll sufficient numbers of subjects in clinical trials; determinations made by the FDA and other governmental authorities, including with respect to products seeking to compete in our market; mislabeling or other misleading marketing practices by competitors; economic and market instability, including as a result of tariffs or trade conflicts; and the risks and uncertainties associated with our business and financial condition in general, described in our filings with the Securities and Exchange Commission (SEC), including, without limitation, our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q as filed with the SEC.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement and Niagen Bioscience undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

†Based on revenue per largest U.S. e-commerce marketplace (Jan. 2025 – Dec. 2025)

Niagen Bioscience Media Contact:
Kendall Knysch, Senior Director of Global Public Relations and Communications
310.405.5227
[email protected]

Niagen Bioscience Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Science Biotechnology Telemedicine/Virtual Medicine Research Pharmaceutical Health Vitamins/Supplements Clinical Trials

MEDIA:

Photo
Photo
Qualified Customers may now purchase the Niagen™ At-Home Injection Kit on www.niagenplus.com using HSA/FSA funds with Truemed
Photo
Photo
Rob Fried, CEO of Niagen Bioscience, remarked, “NAD+ injections are everywhere, but none are backed by published clinical research. We did the research on Niagen injections, and HSA/FSA eligibility puts our science-first approach within reach of more people.”
Logo
Logo

Phunware Interactive Maps and Wayfinding Now Available in Toolbox on Epic Showroom, Bringing Location-Aware Patient Wayfinding to Health Systems

Phunware Brings MyChart Pre-Login Landing Page and Blue-Dot Indoor Wayfinding to Epic Customers

AUSTIN, Texas, Nov. 12, 2026 (GLOBE NEWSWIRE) — Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a mobile-first enterprise patient intelligence platform company, today announced that Phunware Interactive Maps and Wayfinding is now available in the Wayfinding category of Toolbox on Epic Showroom, Epic’s marketplace where anyone can discover products that can connect to Epic. Phunware Patient Digital Front Door is also live in Epic Showroom as a Connection Hub listing.

Large health system campuses can span multiple buildings, parking structures and entrances, and patients and caregivers often arrive anxious, unwell or unfamiliar with the facility, resulting in arriving late or missing appointments that are costly to the health system. Phunware’s technology addresses this common issue. Patients of customers which have partnered with Epic can now receive a landing page in MyChart with directions, parking and visitor information before they sign in, and precise turn-by-turn indoor directions once they arrive on site.

Through Epic Showroom, Phunware offers two healthcare solutions for new and existing healthcare customers:

  • Phunware Patient Digital Front Door (Connection Hub listing). Provides patients, caregivers and visitors with easy access to critical patient resources such as locations, directions, parking, visitor information, scheduling and bill pay from the MyChart login screen before they sign in, in a branded experience each health system configures. Patients know where to go and how to get there before they ever arrive.
  • Phunware Interactive Maps and Wayfinding (Toolbox, Wayfinding category). Helps patients, staff, vendors, caregivers, and visitors navigate complex, multi-building health system campuses turn by turn, with precise indoor positioning and real-time updates to reach the right entrance, department, area and room without stopping to ask for directions.

“Navigation failure in a hospital or health system campus is not an inconvenience. It is a missed or late appointment or procedure and generates significant costs which the administration has to absorb,” said Dmitry Kroshka, Chief Executive Officer of Phunware. “Availability in Toolbox on Epic Showroom puts our healthcare location-aware platform in front of the health systems that partner with Epic. By pairing a MyChart entry point with precise indoor wayfinding we can help hospitals and other health system campuses guide patients, doctors, nurses, other staff and visitors from the parking lot directly to the procedure room and through recovery. This is only the first step. As a next step and part of Phunware 2.0, we are building a location-aware intelligence layer around the appointment itself, so hospitals and other health systems can see who is at risk of arriving late or missing an appointment and act before it happens.”

The announcement marks another step in Phunware’s evolving technology offerings leading to Phunware 2.0, which is envisioned to bring together mobile, location-aware and AI capabilities that typically operate in separate silos into a shared intelligence platform supporting applications in hospitality, healthcare and other verticals involving complex physical environments. Epic’s reach among health systems lets Phunware reach many health systems in the Epic environment they already use, and Phunware’s platform is available to health systems that do not use Epic as well. Health systems interested in Phunware’s Epic-connected capabilities can learn more at phunware.com/industry/healthcare.

About Phunware

Phunware, Inc. (NASDAQ: PHUN) is an enterprise software company specializing in mobile app solutions for hospitality, healthcare, and other large property related customers, with integrated intelligent capabilities. We provide businesses with the tools to create, implement, and manage custom mobile applications, analytics, and location-based services. Phunware is transforming mobile engagement by delivering scalable, personalized, and data-driven mobile app experiences.

Phunware’s mission is to achieve unparalleled connectivity and monetization through the widespread adoption of Phunware mobile technologies, leveraging brands, consumers, partners, and market participants. Phunware is poised to expand its software products and services audience through new generative AI products and product enhancements which are in development, utilize and monetize its patents and other intellectual property, and focus on serving its enterprise customers and partners.

For more information on Phunware, please visit www.phunware.com.

Safe Harbor / Forward-Looking Statements

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our business strategy and plans, our objectives for future operations, the development and delivery of the Phunware Interactive Maps and Wayfinding and Phunware Patient Digital Front Door for Epic customers and our healthcare customers, the development and commercial rollout of our Product 2.0 strategy, and the expansion of our product offering into healthcare and other adjacent end markets, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” and similar expressions are intended to identify forward-looking statements.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on us. These forward-looking statements involve risks, uncertainties, and other assumptions that may cause actual results to differ materially from those expressed or implied. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors” in our filings with the SEC. We undertake no obligation to update any forward-looking statements.

By their nature, forward-looking statements involve risks and uncertainties. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those expressed or implied by these forward-looking statements.

Epic, MyChart and Showroom are trademarks of Epic Systems Corporation.

Media Contact:

Scott Berwitz, Greenpoint Agency
[email protected]

Investor Relations Contact:

Chris Tyson, Executive Vice President
MZ Group – MZ North America
949-491-8235
[email protected]
www.mzgroup.us



Newton Golf ReportsThird Quarter 2026 Results, Expands 2.0 Shaft Rollout and Advances Retailer Discussions

Newton Golf ReportsThird Quarter 2026 Results, Expands 2.0 Shaft Rollout and Advances Retailer Discussions

CAMARILLO, Calif.–(BUSINESS WIRE)–
Newton Golf Company, Inc. (NASDAQ: NWTG) (the “Company”), a technology-forward golf equipment company focused on physics-driven engineering, reported results for the third quarter ended September 30, 2026. Unless otherwise noted, comparisons are to the same period in the prior year.

Financial Highlights

  • Net sales were $1.4 million for the third quarter of 2026, compared to $2.6 million in the prior-year quarter. The decline primarily reflected reduced marketing activity during the transition to a new marketing agency and changes to the Company’s promotional strategy.

  • Gross profit was $820,000, or 59.9% of net sales, compared with $1.7 million, or 67.2% of net sales, in the prior-year quarter. Lower sales volumes caused assembly and pick, pack and shipping labor costs to represent a larger percentage of revenue as the Company maintained its workforce and labor hours.

  • Total operating expenses decreased to $2.2 million from $3.2 million in the prior-year quarter. Selling, general and administrative expenses decreased primarily due to approximately $0.8 million of lower sales and marketing costs, $0.2 million of lower labor costs and $0.1 million of lower public company costs.

  • Loss from operations improved to $1.3 million from $1.5 million in the prior-year quarter, reflecting lower operating expenses, offset by the decrease in gross profit.

  • Net loss was $1.2 million, or $0.23 per basic and diluted share, compared with $1.6 million, or $0.34 per basic and diluted share, in the prior-year quarter. The improvement reflected a noncash gain from changes in the fair value of warrant liabilities and a lower operating loss, partially offset by higher interest expense, deferred financing cost amortization, and a loss on extinguishment of debt.

  • Cash and cash equivalents were $513,000 at September 30, 2026. Subsequent to September 30, 2026, the Company raised approximately $3.0 million in net proceeds from equity financings.

  • Stockholders’ equity was $1.1 million at September 30, 2026. Based on transactions completed through the date hereof, management estimates pro forma stockholders’ equity of approximately $5.2 million.

Q3 2026 Operational Highlights

  • The manufacturing facility operated under normal manufacturing processes during the quarter. The Company began building inventory in advance of customer orders and is targeting shipment within two days of receiving an order.

  • The Company continued selling its 2.0 Fast Motion driver shaft, Motion driver and fairway shafts, introduced in the second quarter and are identified by green product logos. The 2.0 shafts incorporate refinements to manufacturing techniques, bend profiles, specifications and production tolerances designed to support greater product consistency and a broader fitting profile. Initial professional adoption has included conversions from prior-generation shafts and use of the updated Motion fairway shaft by multiple PGA TOUR Champions players. Professional adoption continued to expand, with more than 80 professional golfers using Newton Motion and Fast Motion shafts across the PGA TOUR, PGA TOUR Champions, LPGA and Korn Ferry Tours at quarter end, compared with more than 77 at the end of the second quarter.

  • The Company’s professional club fitter network grew to approximately 301accounts at quarter end, compared with approximately 273 at the end of the second quarter.

  • The Company engaged a new marketing agency to sharpen its direct-to-consumer strategy, broaden customer acquisition channels and strengthen brand messaging. It is moving away from frequent sitewide discounts toward selective promotions and purchase incentives designed to increase order size, reinforce brand positioning, and support wholesale opportunities. The Company also increased prices for its Motion driver and fairway shafts to align them with related product lines. Since marketing initiatives resumed, the Company has observed improved returns on advertising spend. A dedicated campaign for the 2.0 platform is expected to launch in November 2026.

  • In July 2026, the Company entered into a $5.0 million senior secured revolving credit facility and exchanged approximately $2.3 million of convertible notes, including accrued interest, for Series A Convertible Preferred Stock. The exchange included a 5% premium and did not provide cash proceeds. At September 30, 2026, $1.0 million of principal was outstanding under the facility, leaving up to $4.0 million available, subject to its terms. Private placements completed during the nine months ended September 30, 2026 generated approximately $1.2 million of net proceeds.

  • On September 23, 2026, the Company acquired, through assignment of an option agreement, the exclusive option to acquire a 100% interest in the Pole Canyon Project, consisting of 16 unpatented lode mining claims totaling approximately 330 acres in White Pine County, Nevada, in exchange for 1,135,891 shares of common stock with an aggregate fair value of $1.3 million. At September 30, 2026, the option had not been exercised and title to the claims had not transferred to the Company. The Company also assumed $165,000 of remaining cash option payments, payable in eight quarterly installments, and recorded the mineral property option at a total cost of $1,474,000 as an asset acquisition. The Pole Canyon Project is a strategic, non-operating asset. The Company’s current operating forecasts do not include project production, revenue, or cash flows and do not assume material exploration or development spending. Any additional project investment would be evaluated separately by management.

Subsequent Events

  • Subsequent to September 30, 2026, the Company received approximately $1.4 million in net proceeds from ATM sales of 1,344,871 shares at an average price of $1.18 per share, approximately $1.2 million in net proceeds from private placement sales of 967,739 shares at $1.24 per share, and $500,000 in gross proceeds from issuing 5,000 shares of Series A Preferred Stock. The ATM shares were sold at prevailing market prices, while the Company’s other equity issuances were completed at prices above the prevailing market price on the respective transaction dates. On November 6, 2026, the Company converted $1.0 million of revolving credit facility principal, plus a 5% premium, into 211,693 shares of common stock and 7,875 shares of Series A Preferred Stock. The noncash conversion reduced outstanding debt, increased stockholders’ equity and resulted in an approximately $288,000 gain on extinguishment of debt.

  • On October 6, 2026, the Company received a letter from Nasdaq notifying the Company that it had not demonstrated compliance with the $2.5 million minimum stockholders’ equity requirement. The Company requested a hearing before a Nasdaq Hearings Panel (the “Panel”), scheduled for November 12, 2026, and requested an exception under Nasdaq Rule 5815(c)(1)(A) through April 4, 2027 or, alternatively, a finding of compliance under Rule 5815(c)(1)(E). Based on transactions completed through the date hereof, 2026, management estimates stockholders’ equity of approximately $5.2 million. This is the Company’s estimate and has not been confirmed by Nasdaq and the Panel has not issued a decision.

  • The completed financings have strengthened the Company’s liquidity and capital structure. Management expects, however, that additional financing will be required to fund operations and meet obligations during the year following issuance of the financial statements. Management’s plans to obtain additional financing do not alleviate substantial doubt about the Company’s ability to continue as a going concern. Additional financing may not be available on acceptable terms, or at all, and could dilute existing stockholders.

Management Commentary

“In the third quarter, our manufacturing facility operated under normal production processes, and for the first time, we began building inventory ahead of customer orders. This is an important step toward improving product availability and fulfillment. We are targeting shipment within two days of receiving an order,” said Akinobu Yorihiro, interim CEO and CTO of Newton Golf.

“We continued selling our updated 2.0 shafts, which incorporate refinements to manufacturing techniques, bend profiles, specifications and production tolerances. Initial professional adoption has included conversions from prior-generation shafts and use of the updated Motion fairway shaft by multiple PGA TOUR Champions players.

“Reliable supply, shorter lead times and consistent product quality are important to developing wholesale and OEM relationships. We believe our manufacturing improvements and updated shaft versions have strengthened those relationships.

“Our new marketing agency is helping refine our direct-to-consumer strategy, diversify customer acquisition channels and strengthen brand messaging. As carbon fiber availability improved, we selectively resumed marketing initiatives while keeping overall activity below historical levels. We are shifting away from frequent sitewide discounts toward more selective promotions and offers designed to encourage larger purchases. Since marketing initiatives resumed, we have observed improved returns on advertising spend.

“On October 29, we announced the next phase of our expansion in Japan, including the relaunch of our enhanced Japanese e-commerce platform, the local introduction of our 2.0 shafts and a partnership with professional golfer Hiroyuki Fujita.

“We believe our focus on brand building and more selective promotions has helped open discussions with certain key prospective retail partners. We are now negotiating potential commercial arrangements that could expand access to our Motion and Fast Motion shafts through in-store fitting and e-commerce channels.

“We expect to begin a dedicated marketing campaign for the 2.0 platform in November 2026. Fast Motion fairway wood and hybrid shafts are expected to launch commercially in the first quarter of 2027. Our priorities are to improve fulfillment and product consistency, expand distribution and prepare for upcoming product launches.”

Third Quarter 2026 Financial Summary

Net sales totaled $1.4 million in the third quarter of 2026, a 47% decrease from the prior-year quarter. The decline primarily reflected reduced marketing activity during the transition to a new marketing agency, including limited spending in June and July, and changes to the Company’s promotional strategy. Marketing activity resumed in August. During the quarter, the facility operated under normal manufacturing processes, and the Company began building inventory to improve product availability and fulfillment.

Gross profit totaled $820,000, or 59.9% of net sales, compared with $1.7 million, or 67.2% of net sales, in the prior-year quarter. Lower sales volumes caused assembly and pick, pack and shipping labor costs to represent a larger percentage of revenue as the Company maintained its workforce and labor hours.

Total operating expenses decreased to $2.2 million from $3.2 million in the prior-year quarter. Selling, general and administrative expenses decreased to $2.0 million from $3.1 million, primarily reflecting approximately $0.8 million of lower sales and marketing costs, $0.2 million of lower labor costs and $0.1 million of lower public company costs. Research and development expenses were $198,000, compared with $182,000. Loss from operations improved to $1.3 million from $1.5 million.

Net loss was $1.2 million, or $0.23 per basic and diluted share, compared with $1.6 million, or $0.34 per basic and diluted share, in the prior-year quarter. The improvement reflected a lower operating loss and a $302,000 noncash gain from changes in the fair value of warrant liabilities, compared with a $96,000 noncash loss from warrant liabilities in the prior-year quarter. These improvements were partially offset by higher net interest expense, amortization of deferred financing costs and a loss on extinguishment of debt.

First Nine Months 2026 Financial Summary

Net sales were $3.7 million for the nine months ended September 30, 2026, a 37% decrease from $5.9 million in the prior-year period. During the first six months, manufacturing transition activities and temporary carbon fiber supply constraints reduced production throughput and delayed certain shipments. In the third quarter, the facility operated under normal manufacturing processes, while sales were affected by reduced marketing activity during the transition to a new agency and changes to the Company’s promotional strategy.

Gross profit was $2.4 million, or 64.2% of net sales, compared with $4.0 million, or 68.0% of net sales, in the prior-year period. The decrease reflected manufacturing inefficiencies and idle capacity during the first six months, as well as third-quarter labor costs that did not decline in proportion to lower sales.

Total operating expenses decreased to $7.8 million from $9.0 million in the prior-year period. Selling, general and administrative expenses decreased to $7.0 million from $8.4 million, primarily reflecting approximately $1.8 million of lower sales and marketing expenses, partially offset by approximately $0.5 million of idle manufacturing costs, $0.2 million of increased stock-based compensation expense and a $0.1 million increase in professional services, among other items. Research and development expenses increased to $894,000 from $607,000, primarily reflecting manufacturing labor reclassified to research and development for product and manufacturing process improvements. Loss from operations was $5.5 million, compared with $5.0 million.

Net loss was $6.2 million, or $1.27 per basic and diluted share, compared with $3.6 million, or $1.07 per basic and diluted share, in the prior-year period. The increase reflected a higher operating loss and an unfavorable $1.7 million change in warrant valuations, from a $1.3 million noncash gain in the prior-year period to a $382,000 noncash loss in the current period. The current-period results also included interest expense, amortization of debt discount and deferred financing costs, and a loss on extinguishment of debt.

About Newton Golf

At Newton Golf, we apply the principles of physics to the design and performance of premium golf equipment. Formerly known as Sacks Parente, our rebranding reflects our commitment to innovation inspired by Sir Isaac Newton, the father of physics. By applying Newtonian principles to every aspect of our design process, we create precision-engineered golf equipment including Newton Motion shafts and Gravity putters that deliver unmatched stability, control, and performance. Our mission is to empower golfers with scientifically advanced tools that maximize consistency and accuracy, ensuring every swing is backed by the laws of physics. For more information, visit newtongolf.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or the future financial performance of Newton Golf Company (the “Company”) and involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements.

In some cases, forward-looking statements can be identified by words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “projects,” “potential,” or similar expressions. These forward-looking statements include, but are not limited to, statements regarding the Company’s ability to support working capital needs, operational scaling initiatives, and future growth opportunities, growth strategy, product innovation and development, expansion of distribution channels, brand adoption among professional fitters and golfers, anticipated market opportunities, future business prospects, inventory-building and two-day shipment goals, anticipated timing of product launches and marketing campaigns, expected operating leverage, additional financing needs, the mineral property option, and the Company’s ability to regain and maintain compliance with Nasdaq’s continued listing requirements and maintain the listing of its common stock on Nasdaq.

These forward-looking statements reflect the Company’s current expectations and projections based on information available as of the date of this release and are subject to a number of risks and uncertainties, including, but not limited to, general economic and business conditions; changes in consumer demand and industry trends; competition in the golf equipment market; the Company’s ability to execute its strategic initiatives; supply chain disruptions; the availability of additional financing on acceptable terms and potential dilution; the Company’s ability to obtain additional debt or equity financing and achieve improved operating performance, upon which its ability to continue as a going concern depends; the outcome of Nasdaq proceedings; and the ability to reach definitive distribution agreements; and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.

The Company cautions investors that forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.

The Company will not host a conference call in connection with its third-quarter 2026 financial results.

NEWTON GOLF COMPANY, INC.

CONDENSED STATEMENTS OF OPERATIONS

For the Three and Nine months ended September 30, 2026 and 2025

(Unaudited)

(Amounts rounded to nearest thousand, except share and per share amounts)

 

 

 

Three Months Ended

September 30,

 

 

Nine months ended

September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

 

 

 

 

 

 

Net sales

 

$

1,368,000

 

 

$

2,582,000

 

 

$

3,675,000

 

 

$

5,860,000

 

Cost of goods sold

 

 

548,000

 

 

 

848,000

 

 

 

1,316,000

 

 

 

1,875,000

 

Gross profit

 

 

820,000

 

 

 

1,734,000

 

 

 

2,359,000

 

 

 

3,985,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

1,954,000

 

 

 

3,056,000

 

 

 

6,952,000

 

 

 

8,360,000

 

Research and development

 

 

198,000

 

 

 

182,000

 

 

 

894,000

 

 

 

607,000

 

Total operating expenses

 

 

2,152,000

 

 

 

3,238,000

 

 

 

7,846,000

 

 

 

8,967,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(1,332,000

)

 

 

(1,504,000

)

 

 

(5,487,000

)

 

 

(4,982,000

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest (expense) income, net

 

 

(93,000

)

 

 

20,000

 

 

 

(138,000

)

 

 

94,000

 

Amortization of debt discount

 

 

–

 

 

–

 

 

 

(37,000

)

 

 

–

 

Amortization of deferred financing costs

 

 

(20,000

)

 

 

–

 

 

 

(20,000

)

 

 

–

 

Loss on extinguishment of debt

 

 

(96,000

)

 

 

–

 

 

 

(96,000

)

 

 

–

 

Loss on disposal of asset

 

 

–

 

 

 

–

 

 

 

(16,000

)

 

 

–

 

Change in fair value of warrant liabilities

 

 

302,000

 

 

 

(96,000

)

 

 

(382,000

)

 

 

1,263,000

 

Net loss

 

$

(1,239,000

)

 

$

(1,580,000

)

 

$

(6,176,000

)

 

$

(3,625,000

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share – basic and diluted

 

$

(0.23

)

 

$

(0.34

)

 

$

(1.27

)

 

$

(1.07

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding – basic and diluted

 

 

5,378,240

 

 

 

4,602,070

 

 

 

4,860,030

 

 

 

3,395,389

 

NEWTON GOLF COMPANY, INC.

CONDENSED BALANCE SHEETS

 

(Amounts rounded to nearest thousand, except share and per share amounts)

 

 

 

September 30,

2026

 

 

December 31,

2025

 

 

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

513,000

 

 

$

1,298,000

 

Accounts receivable, net

 

 

255,000

 

 

 

102,000

 

Inventory, net of reserve for obsolescence of $60,000 and $135,000, respectively

 

 

780,000

 

 

 

374,000

 

Prepaid expenses and other current assets

 

 

601,000

 

 

 

413,000

 

Total Current Assets

 

 

2,149,000

 

 

 

2,187,000

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

780,000

 

 

 

880,000

 

Right-of-use asset, net

 

 

55,000

 

 

 

84,000

 

Software licensing agreement, net

 

 

–

 

 

 

25,000

 

Deferred financing costs

 

 

144,000

 

 

 

–

 

Deferred offering costs

 

 

189,000

 

 

 

123,000

 

Mineral property option

 

 

1,474,000

 

 

 

–

 

Total Assets

 

$

4,791,000

 

 

$

3,299,000

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

1,942,000

 

 

$

1,428,000

 

Customer deposits

 

 

3,000

 

 

 

75,000

 

Lease liability, current

 

 

43,000

 

 

 

40,000

 

Software licensing obligation, current

 

 

–

 

 

 

41,000

 

Note payable – mineral property option

 

 

83,000

 

 

 

–

 

Warrant liability

 

 

488,000

 

 

 

745,000

 

Total Current Liabilities

 

 

2,559,000

 

 

 

2,329,000

 

 

 

 

 

 

 

 

 

 

Lease obligations – noncurrent

 

 

12,000

 

 

 

44,000

 

Line of credit – noncurrent

 

 

1,000,000

 

 

 

–

 

Notes payable – mineral rights

 

 

82,000

 

 

 

–

 

Total Liabilities

 

 

3,653,000

 

 

 

2,373,000

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

 

 

Series A Preferred Stock $.01 par value, 5,000,000 shares authorized, 24,093 and 0 shares issued and outstanding, respectively

 

 

2,144,000

 

 

 

–

 

Common stock, $.01 par value, 45,000,000 shares authorized, 7,651,166 and 4,592,063 shares issued and outstanding

 

 

77,000

 

 

 

45,000

 

Additional paid-in-capital

 

 

33,182,000

 

 

 

28,970,000

 

Accumulated deficit

 

 

(34,265,000

)

 

 

(28,089,000

)

Total Stockholders’ Equity

 

 

1,138,000

 

 

 

926,000

 

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders’ Equity

 

$

4,791,000

 

 

$

3,299,000

 

The pro forma balance sheet below reflects the effect of financing transactions completed through November 9, 2026.

NEWTON GOLF COMPANY, INC.

PRO FORMA BALANCE SHEET

 

(Amounts rounded to nearest thousand)

 

 

 

As Reported September 30,

2026

 

 

Post

September 30 Adjustments

 

 

Note

 

Pro Forma

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

513,000

 

 

$

3,224,000

 

 

1,2,3

 

$

3,737,000

 

Prepaid expenses and other current assets

 

 

1,636,000

 

 

 

(189,000

)

 

1

 

 

1,447,000

 

Total Current Assets

 

 

2,149,000

 

 

 

3,035,000

 

 

 

 

 

5,184,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mineral rights and other assets

 

 

2,642,000

 

 

 

–

 

 

 

 

 

2,642,000

 

Total Assets

 

$

4,791,000

 

 

$

3,035,000

 

 

 

 

$

7,826,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

$

2,559,000

 

 

$

–

 

 

 

 

$

2,559,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other noncurrent liabilities

 

 

94,000

 

 

 

–

 

 

 

 

 

94,000

 

Line of credit – noncurrent

 

 

1,000,000

 

 

 

(1,000,000

)

 

4

 

 

–

 

Total Liabilities

 

 

3,653,000

 

 

 

(1,000,000

)

 

 

 

 

2,653,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Series A Preferred stock

 

 

2,144,000

 

 

 

1,061,000

 

 

3,4

 

 

3,205,000

 

Common stock and additional paid-in-capital

 

 

33,259,000

 

 

 

2,686,000

 

 

1,2,4

 

 

35,945,000

 

Accumulated deficit

 

 

(34,265,000

)

 

 

288,000

 

 

4

 

 

(33,977,000

)

Total Stockholders’ Equity

 

 

1,138,000

 

 

 

4,035,000

 

 

 

 

 

5,173,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders’ Equity

 

$

4,791,000

 

 

$

3,035,000

 

 

 

 

$

7,826,000

 

NOTES TO UNAUDITED PRO FORMA BALANCE SHEET

(1)

 

Reflects the sale of 1,344,871 shares of common stock under the Company’s at-the-market offering program at an average price of $1.18 per share. The sale generated gross proceeds of approximately $1.6 million and net cash proceeds of approximately $1.4 million after offering costs. The increase in stockholders’ equity was approximately $1.4 million after amortization of capitalized deferred offering costs.

 

(2)

 

Reflects the sale of 967,739 shares of common stock in a private placement at a price of $1.24 per share. The Company received net cash proceeds of approximately $1.2 million after deducting offering costs.

 

(3)

 

Reflects a direct investment of $500,000 for the issuance of 5,000 shares of the Company’s Series A Convertible Preferred Stock.

 

(4)

 

Reflects an exchange agreement with the holder of the revolving line of credit, pursuant to which $750,000 of principal was exchanged for 7,875 shares of the Company’s Series A Preferred Stock with a fair value of $561,000. 

 

In addition, the holder exchanged $250,000 of principal for 211,693 shares of common stock with a fair value of $151,000. The Company recognized an approximately $288,000 gain on extinguishment of debt.

 

Company Contact

Jeff Clayborne

CFO and COO

Tel (855) 563-9866

Email Contact

Investor Relations Contact

Ron Both or Grant Stude

Encore Investor Relations

Tel (949) 432-7557

Email Contact

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Sports Other Manufacturing Golf Specialty Engineering Online Retail Manufacturing Retail

MEDIA:

Logo
Logo